[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing November 16, 2020

With the news on the novel coronavirus pandemic ever-changing, and the search for COVID-19 vaccines still continuing, it is difficult to stay on top of the goings-on of the vaccines in development. To help you stay on top of things, Nidhi Parekh of The Shared Microscope writes weekly updates on the vaccines alone.

Struggling to keep up with the goings-on of the COVID-19 vaccines?! We’ve got you covered! Check out our weekly COVID-19 Newsletter for the latest information on COVID-19 drugs and vaccines. #TSMUpdates #VaccineInfo #COVID19Updates


For weekly updates on the COVID-19 vaccines, please do not forget to subscribe using the form below:

Processing…
Success! You're on the list.

COVID-19 Top Vaccines

There are currently 14 COVID-19 vaccines in the final phase of clinical trials. The final phase results of all these vaccines are currently awaited. For more information on the regulatory process for vaccines (which is a labyrinth), check out this post here.


1. The Oxford/AstraZeneca Vaccine

What is The Oxford/AstraZeneca Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Just today, the University of Oxford has announced that their interim data show that their COVID-19 vaccine candidate is 70.4% effective, and tests on using a two-dose regimen show that it could be 90% effective.


2. The Moderna Vaccine

What is The Moderna Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, Moderna announced that they had secured a supply agreement with the United Kingdom for their vaccine candidate is approved for use. 

The European Medicines Agency, too, has begun a rolling review of this vaccine candidate.


3. Sinovac’s CoronaVac Vaccine

What is The CoronaVac Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

According to the results published in The Lancet, the CoronaVac vaccine candidate triggered a quick immune response against the SARS-CoV-2 virus. 

Indonesia has a deal in place for 85 million doses of this vaccine from Sinovac Biotech.


4. Cansino’s Ad5-nCoV

What is Cansino’s Ad5-nCoV Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


5. Unnamed Inactive Vaccine – Wuhan

What is The Inactive Virus Vaccine From Wuhan And How Does It Work?

This image has an empty alt attribute; its file name is 9-1.png

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


6. Sinopharm’s BBIBP-CorV

What is Sinopharm’s BBIBP-CorV And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


7. Pfizer and BioNTech’s BNT162b2

What is Pfizer and BioNTech’s BNT162 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, Pfizer completed their Phase 3 study for the RNA-based vaccine candidate, BNT162b2. Results revealed 95% efficacy against COVID-19 and good tolerance overall. 


8. The Russian Gam-COVID-Vac

What is the Gam-COVID-Vac And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Last week, Gamaleya announced early results from their COVID-19 vaccine candidate, which suggested it could be 92% effective. There have been no new updates this week.


9. Novavax’s NVX-CoV2373

What is Novavax’s NVX-CoV2373 And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

According to Bloomberg, Indonesia has secured a deal for 30 million doses of Novavax’s vaccine candidate. 


10. Johnson & Johnson’s JNJ-78436735/Ad26.CoV2-S

What is Johnson & Johnson’s COVID-19 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


11. Murdoch Children’s Research Institute’s BCG Vaccine Trial

What is Murdoch Children’s Research Institute Doing?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Phase 3 clinical trial results for this vaccine are still to be declared. Since the trials started, we haven’t had any updates on the use of the BCG vaccine against COVID-19.


12. Bharat BioTech’s Covaxin

What is Bharat BioTech’s Covaxin And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

India’s vaccine against COVID-19 is said to be at least 60% effective and it is expected to be rolled out mid-2021.


13. The Medicago-GSK Coronavirus-Like Particle (CoVLP)

What is Medicago’s Coronavirus-Like Particle (CoVLP)?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


14. Anhui Zhifei Longcom and Chinese Academy of Medical Sciences Vaccine Candidate

What is Anhui Zhifei Longform’s vaccine based on?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, the Anhui Zhifei Longcom and Chinese Academy of Medical Sciences joined the above vaccines in launching phase 3 clinical trials.  


For weekly updates on the COVID-19 vaccines delivered straight to your inbox, please do not forget to subscribe using the form below:

Processing…
Success! You're on the list.

2 Replies to “[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing November 16, 2020”

  1. Thanks for the timely updates.
    Could you also shed some light on how the vaccines are produced? Will there be a shortage of cold storage facilities in the supply chain? Development of the vaccine is almost through so what are the next big challenges?

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s